MediWound (MDWD) Share-based Compensation (2013 - 2026)
MediWound (MDWD) posted quarterly Share-based Compensation of $662000.0 for Q4 2025, down 19.46% year-over-year from $822000.0 in Q4 2024, and down 10.54% quarter-over-quarter from $740000.0 in Q3 2025.
MediWound (MDWD) Share-based Compensation (2013 - 2026) Analysis & Trends
MediWound's Share-based Compensation history runs 13 years deep, the most recent figure standing at $662000.0 for Q4 2025.
- In Q4 2025, Share-based Compensation fell 19.46% year-over-year to $662000.0; the TTM figure through Dec 2025 stood at $3.1 million (down 0.96% YoY), while the FY2025 annual figure was $3.1 million, down 0.96% from the prior year.
- Share-based Compensation for Q4 2025 stood at $662000.0, down from $740000.0 in the prior quarter.
- The five-year high for Share-based Compensation was $1.0 million in Q3 2024, with the low at $252000.0 in Q2 2022.
- The 5-year median for Share-based Compensation is $630500.0 (2022), against an average of $590250.0.
- The sharpest annual moves came in 2023 and 2024: Share-based Compensation plunged 56.01% in 2023, then jumped 236.33% in 2024.
- MediWound's Share-based Compensation stood at $390000.0 in 2021, then surged by 64.62% to $642000.0 in 2022, then slumped by 53.58% to $298000.0 in 2023, then surged by 175.84% to $822000.0 in 2024, then decreased by 19.46% to $662000.0 in 2025.
- Business Quant data shows MDWD's Share-based Compensation at $662000.0 in Q4 2025, $740000.0 in Q3 2025, and $862000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 108.10 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 243.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 120.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 137.41 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 86.63 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 41.25 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 28.05 Mn |
| 10 | MediWound | 169.29 Mn | 138.30 Mn | 337,000.00 | 755,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 755,000.00 |
| Jun 30, 2026 | 755,000.00 |
| Dec 31, 2025 | 662,000.00 |
| Dec 31, 2025 | 662,000.00 |
| Sep 30, 2025 | 740,000.00 |
| Sep 30, 2025 | 740,000.00 |
| Jun 30, 2025 | 862,000.00 |
| Jun 30, 2025 | 862,000.00 |
| Mar 31, 2025 | 844,000.00 |
| Mar 31, 2025 | 844,000.00 |
| Dec 31, 2024 | 822,000.00 |
| Dec 31, 2024 | 822,000.00 |
| Sep 30, 2024 | 1.05 Mn |
| Sep 30, 2024 | 1.05 Mn |
| Jun 30, 2024 | 758,000.00 |
| Jun 30, 2024 | 758,000.00 |
| Mar 31, 2024 | 512,000.00 |
| Mar 31, 2024 | 512,000.00 |
| Dec 31, 2023 | 298,000.00 |
| Dec 31, 2023 | 298,000.00 |